alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31



CERTIFICATION PURSUANT TO RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED



I, Joseph R. Rozelle, certify that:



1.   I have reviewed this Annual Report on Form 10-K/A of Juniper Growth Corporation;



2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;



4.   The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



5.   The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and



(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.





Date:  November 24, 2009



/s/    Joseph R. Rozelle

------------------------------------

Joseph R. Rozelle

Principal Executive Officer

and Principal Financial Officer
**Annual
      Statement of Compliance**





VIA:
      EMAIL





Merrill
      Lynch Mortgage Investors, Inc.


250
      Vesey
      Street


4
      World
      Financial Center, 10th Floor


New
      York,
      New York 10080





Wilshire
      Credit Corporation


14523
      SW
      Millikan Way


Suite
      200


Beaverton,
      Oregon 97005





Attention:
      Merrill Lynch Mortgage Investors Trust, Series 2006-HE6





Re:
      Pooling and Servicing Agreement (the "Agreement") dated as of December 1, 2006
      among Merrill Lynch Mortgage Investors, Inc., as depositor, Wilshire Credit
      Corporation, as servicer, and LaSalle Bank National Association, as trustee,
      relating to Merrill Lynch Mortgage Investors Trust, Mortgage Loan Asset-Backed
      Certificates, Series 2006-HE6





I,
      Barbara L. Marik, a First Vice President of LaSalle Bank National Association,
      as Trustee hereby certify that:





(1)
      A
      review of the activities of the Trustee during the preceding calendar year
      and
      of the performance of the Trustee under the Agreement has been made under my
      supervision; and





(2)
      To
      the best of my knowledge, based on such review, the Trustee has fulfilled all
      its obligations under the Agreement in all material respects throughout such
      year or a portion thereof.











Date: February
      1, 2007





LaSalle
      Bank National Association, as Trustee








/s/
      Barbara L Marik


Barbara
      L. Marik


First
      Vice President
Final Notes July 9 , 2010 

### Steam Study Data Review Notes Total Dissolved Solids Standard Method 2540C (1991) ( Dried at 180 °C )

1. T he sample should be brought to room temperature before analysis

. 2. S ample volumes should be selected so that 10

- 200 mg of dry residue would be acquired

. If t he filtrati on took longer than 10 minutes, the filter size should be increased or the sample volume decreased (2540C/3c) . T he sample size should be decreased if evaporation of the filtrate resulted in more than 200 mg of residue (2540C/1b)

. 3. After filtratio n, at least three aliquots of 10 ml of reagent

- grade water should be ad ded to the sample/filter and suction contin ued for 3 minutes after washing (2540C/3d)

. 4. T he filtrate and all washings should be transferred to the evaporating dish and dried with a steam bath or drying oven? The e vaporated sample should be further dried in an oven for 1 hour at 180 ± 2°C, cooled in a desiccator, and weighed . T he above process should be rep eated until the weight change i s less than 4% of the previous weight or 0.5 mg (whic hever is less)

. 5. If laboratory duplicates were run, duplicate weights should be within 5% of their average

. If applicable, indicate whether this criteria was met and specify the average and percent recovery from the average for each of the samples.
6. Samples may contain calcium, magnesium, chloride and/or sulfate. Such species ma y make the sample hygroscopic. T he following procedures should be done in order to prevent errors: drying time increased, proper dessication procedures us ed, and samples weighed rapidl y (2540C/ 1b)

. 7. T he oven thermometer should be immersed in a sand bath or other suitable thermal mass

. 8. T he desiccator should have a good seal (vacuum or grease)

. 9. D esiccant should be kept inside the balance to maintain humidity control in the balance

. 10. T he o ven temperature should be checked for proper setting and stability and the temperature recorded . If reported, indicate the oven temperature.
11. T he balance should be checked with “S” class weights (100 mg, 1 g, and 100 g)

. 12. T he analytical balance should have b een serviced and calibrated within the last year . If provided, indicate the last date of service.
# Official Journal C 190/2012

| | ISSN 1977-091X
  doi:10.3000/1977091X.C_2012.190.eng |
| --- | --- |
| Official Journal
  of the European Union | C 190 |
| | |
| English edition | Information and Notices | Volume 5529 June 2012 |

ISSN 1977-091X

doi:10.3000/1977091X.C_2012.190.eng

Official Journal

of the European Union

C 190

English edition

Information and Notices

Volume 5529 June 2012

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2012/C 190/01 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2012 to 31 May 2012(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) | 1 |
| 2012/C 190/02 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2012 to 31 May 2012(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) | 12 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2012/C 190/01

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2012 to 31 May 2012(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

1

2012/C 190/02

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2012 to 31 May 2012(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

12

---

| EN | |
| --- | --- |

EN
Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SEC. 1350

(SECTION 906 OF SARBANES-OXLEY ACT OF 2002)

 

In connection with the Annual Report of, Xcellink International, Inc. (the "Company") on Form 10-K for the period ending December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Mark Fingarson, President, Chief Executive Officer, Chief Financial Officer and Director of the Company, hereby certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

 

 (1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated:  April 14, 2009

 

By:  /s/ Mark Fingarson

|   | ----------------------------------------------- |
|--------|-------------------------------------------------|

|   | Mark Fingarson, President, |
|--------|----------------------------|

|   | Chief Executive Officer, |
|--------|--------------------------|

|   | Chief Financial Officer and Director |
|--------|--------------------------------------|
##### 



EXHIBIT 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
GA FINANCIAL, INC.

In connection with the Quarterly Report of GA Financial, Inc. (the
Company) on Form 10-Q for the period ended March 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, James
V. Dionise, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:



| | 1. |  | The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and                                                                              
| | -- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
| | 2. |  | The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations
of the Company as of and for the period covered by the Report.

/s/ James V. Dionise




A signed original of this written statement required by ss. 906 has been
provided to GA Financial, Inc. and will be retained by GA Financial, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.
<PAGE>

                                  EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Celerity Systems,  Inc. (the
"Company")  on Form 10-QSB for the period  ended June 30, 2003 as filed with the
Securities and Exchange  Commission on the date hereof (the  "Report"),  each of
the  undersigned,  in the capacities and on the dates  indicated  below,  hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to his knowledge:

         1. The Report fully complies with the  requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. The  information  contained in the Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of  operation of the
Company.

Date:    August 13, 2003           By: /s/ Robert Legnosky
                                       -----------------------------------------
                                       Robert Legnosky, President and
                                       Interim Chief Financial Officer

         A signed original of this written statement required by Section 906, or
other  document  authentications,   acknowledging,  or  otherwise  adopting  the
signature  that  appears in typed form  within  the  electronic  version of this
written  statement  required  by Section  906,  has been  provided  to  Celerity
Systems,  Inc. and will be retained by Celerity  Systems,  Inc. and furnished to
the Securities and Exchange Commission or its staff upon request.


                                       25
Exhibit
32.1
 
 CERTIFICATIONS
PURSUANT TO 18 U.S.C. SECTION 1350
 
 In
connection with the Annual Report of Great East Bottles & Drinks (China)
Holdings, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2009
as filed with the Securities and Exchange Commission on the date hereof (the
“Report”), the undersigned hereby certifies, pursuant to 18 U.S.C. section 1350,
as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that, to
the best of the undersigned’s knowledge:
 
 (1)           The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 (2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company for the period
certified.
 
 
 Signed on
this March 23, 2010
 
 /s/ Stetson ChungName:
      Stetson ChungTitle:  Chief
      Executive Officer
xml version="1.0" encoding="UTF-8"?


L\_2004176EN.01000802.xml


| | | | |
| --- | --- | --- | --- |
| 11.5.2004 | EN | Official Journal of the European Union | L 176/8 |

---

Corrigendum to Commission Decision 2004/364/EC of 6 April 2004 concerning protection measures in relation to highly pathogenic avian influenza in Canada

(
[Official Journal of the European Union L 114 of 21 April 2004](http://publications.europa.eu/resource/oj/JOL_2004_114_R_TOC)
)

On page 23, in Article 3, paragraph 1, the following words shall be deleted:

‘... of the products mentioned in Article 2 ...’.

---
III

104TH CONGRESS

2D SESSION S. RES. 225

Urging the President to undertake measures to facilitate the immediate

withdrawal of the Iranian Revolutionary Guards from Bosnia-Herzegovina.

IN THE SENATE OF THE UNITED STATES

FEBRUARY 7, 1996

Mr. ROBB submitted the following resolution; which was referred to the

Committee on Foreign Relations

RESOLUTION

Urging the President to undertake measures to facilitate

the immediate withdrawal of the Iranian Revolutionary

Guards from Bosnia-Herzegovina.

Whereas units of the Iranian Revolutionary Guards, including

military trainers and intelligence officers posing as humanitarian relief officials, are still present in BosniaHerzegovina;

Whereas the presence of the Revolutionary Guards in BosniaHerzegovina violates the peace accord initialed in Dayton,

Ohio, on November 21, 1995 and the subsequent treaty

signed in Paris, France, on December 14, 1995, which

provide that all foreign volunteer troops be withdrawn

from Bosnia-Herzegovina within 30 days of the signing

of the treaty, that is, January 13, 1996;
2

•SRES 225 IS

Whereas the commanders of the NATO Implementation

Force in Bosnia-Herzegovina consider the activities of the

Revolutionary Guards in Bosnia-Herzegovina, including

their espousal and promotion of extremist Islamic fundamentalism, to be one of the most direct threats to the

safety of United States forces in Bosnia-Herzegovina;

Whereas the continued presence of the Revolutionary Guards

in Bosnia-Herzegovina threatens long-term stability in

the region; and

Whereas the continuation of arms shipments from Iran to

Bosnia-Herzegovina could preclude the United States

from fulfilling its promise of providing military equipment and training to Bosnia-Herzegovina: Now, therefore, be it

1 Resolved, That it is the sense of the Senate that the

2 President should—

3 (1) pursue all measures necessary, including

4 substantial diplomatic pressure on Bosnia5 Herzegovina, to expedite the withdrawal from

6 Bosnia-Herzegovina of all foreign troops whose pres7 ence in Bosnia-Herzegovina violates the peace accord

8 initialed in Dayton, Ohio, on November 21, 1995,

9 and the subsequent treaty signed in Paris, France,

10 on December 14, 1995;

11 (2) bring in the United Nations a proposal to

12 ban Member States from importing Iranian oil in

13 order to pressure the Iranian Government into with-
3

•SRES 225 IS

1 drawing the Iranian Revolutionary Guards from

2 Bosnia-Herzegovina; and

3 (3) establish within the NATO Implementation

4 Force in Bosnia-Herzegovina a multi-national task

5 force whose mission shall be, if called upon, to locate

6 and ensure the withdrawal of the Revolutionary

7 Guards from Bosnia-Herzegovina.

Æ
----

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO****18 U.S.C. SECTION 1350,****AS ADOPTED PURSUANT TO****SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Golden Elephant Glass Technology, Inc., a Nevada corporation (the “Company”), on Form 10-Q for the quarterly period ending September 30, 2009 as filed with the Securities and Exchange Commission(the “Report”), I, Lin Tan, Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350), that to my knowledge:

     (1) 

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

     (2) 

The information contained in the Report fairly presents, in allmaterial respects, the financial condition and result of operations of theCompany. 

*/s/ Lin Tan*
#### UNITED STATES of America, Plaintiff-Appellee v. William Solomon LEWIS, Defendant-Appellant

No. 17-20358

United States Court of Appeals, Fifth Circuit.

Filed January 10, 2018

James Lee Turner, Carmen Castillo Mitchell, Assistant U.S. Attorneys, U.S. Attorney’s Office, Southern District of Texas, Houston, TX, for Plaintiff-Appellee

William Solomon Lewis, Pro Se

Before, SMITH, CLEMENT, and HAYNES, Circuit Judges. .

PER CURIAM: *

William Solomon Lewis, federal prisoner # 73998-279, has filed a motion for leave .to proceed in forma pauperis (IFP) on appeal. To obtain leave to proceed IFP on appeal, Lewis must demonstrate financial eligibility and a nonfrivolous issue for appeal. *See*FED. R. APP. P. 24(a); 28 U.S.C. § 1915(a)(1); *Carson v. Polley,*689 F.2d 562, 586 (5th Cir. 1982).

In this case, Lewis seeks to appeal the district court’s denial of his motion for release pending collateral review. Lewis argues in his IFP motion that he was deprived of counsel at his sentencing hearing without receiving the necessary warnings about proceeding pro se. He contends that in light of this constitutional error, he is entitled to a new sentencing hearing under- the current version of the Sentencing Guidelines, which will likely result in a guidelines sentencing range lower than the prison term he has already served. Although the district court stated at the original sentencing hearing that it would have sentenced Lewis to the same 110-month sentence, even if it had erred in the guidelines calculations, based on Lewis’s criminal history and lack of respect for the law, Lewis asserts that these statements are insufficient to justify a sentencing above what he believes will be the newly applicable guidelines range.

A review of the record and Lewis’s pleadings shows that he has established his financial eligibility for IFP status. *See Adkins v. E.I. Du Pont de Nemours & Co.,*335 U.S. 331, 339-40, 69 S.Ct. 85, 93 L.Ed. 43 (1948). However, Lewis has not shown that he will raise a nonfrivolous issue on appeal. Release should be granted to an offender pending collateral review “only when the [applicant] has raised substantial constitutional claims upon which he has a high probability of success, and also when extraordinary or exceptional circumstances *209exist which make the grant of bail necessary to make the habeas remedy effective.” Cal*ley v. Callaway,*496 F.2d 701, 702 (5th Cir. 1974). Regardless of the merits of Lewis’s claims, on which the district court has not yet ruled, Lewis has failed to show the existence of any “extraordinary or exceptional circumstances” necessitating his release on bond to make the post-conviction remedy effective. Because Lewis has not demonstrated that he will raise a nonfrivolous issue on appeal, his motion for leave to proceed IFF on appeal is DENIED. His motion for bail and motion to expedite the bail motion are also DENIED. Lewis’s appeal is DISMISSED as frivolous. *See*5TH CIR. R. 42.2.

*

 Pursuant to 5TH CIR. R. 47,5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5TH CIR. R. 47.5,4.